Multinational corporations and infectious disease: Embracing human rights management techniques

Infectious Diseases of Poverty

Jürg Utzinger¹  Mark Wielga³  Gary R Krieger³  Mirko S Winkler¹  Mitchell G Weiss¹  Burton H Singer²  Kendyl Salcito³ 

[1] University of Basel, P.O. Box, CH-4003, Basel, Switzerland;Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA;NewFields, LLC, Denver, CO 80202, USA

关键词: Corporate social responsibility;    Multinational corporations;    Systems-based interventions;    Human rights;    Infectious diseases;   

Others  :  1135981
DOI  :  10.1186/2049-9957-3-39

 received in 2014-05-15, accepted in 2014-10-11,  发布年份 2014

【 摘 要 】

Background

Global health institutions have called for governments, international organisations and health practitioners to employ a human rights-based approach to infectious diseases. The motivation for a human rights approach is clear: poverty and inequality create conditions for infectious diseases to thrive, and the diseases, in turn, interact with social-ecological systems to promulgate poverty, inequity and indignity. Governments and intergovernmental organisations should be concerned with the control and elimination of these diseases, as widespread infections delay economic growth and contribute to higher healthcare costs and slower processes for realising universal human rights. These social determinants and economic outcomes associated with infectious diseases should interest multinational companies, partly because they have bearing on corporate productivity and, increasingly, because new global norms impose on companies a responsibility to respect human rights, including the right to health.

Methods

We reviewed historical and recent developments at the interface of infectious diseases, human rights and multinational corporations. Our investigation was supplemented with field-level insights at corporate capital projects that were developed in areas of high endemicity of infectious diseases, which embraced rights-based disease control strategies.

Results

Experience and literature provide a longstanding business case and an emerging social responsibility case for corporations to apply a human rights approach to health programmes at global operations. Indeed, in an increasingly globalised and interconnected world, multinational corporations have an interest, and an important role to play, in advancing rights-based control strategies for infectious diseases.

Conclusions

There are new opportunities for governments and international health agencies to enlist corporate business actors in disease control and elimination strategies. Guidance offered by the United Nations in 2011 that is widely embraced by companies, governments and civil society provides a roadmap for engaging business enterprises in rights-based disease management strategies to mitigate disease transmission rates and improve human welfare outcomes.

【 授权许可】

   
2014 Salcito et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Bos KI, Schuenemann VJ, Golding GB, Burbano HA, Waglechner N, Coombes BK, McPhee JB, DeWitte SN, Meyer M, Schmedes S, Wood J, Earn DJ, Herring DA, Bauer P, Poinar HN, Krause J: A draft genome of Yersinia pestis from victims of the Black Death. Nature 2011, 478(7370):506-510.
• [2]Porter S: The Great Plague. Gloucestershire: Amberley Publishing; 2009.
• [3]Isaäcson M: Airport malaria: a review. Bull World Health Organ 1989, 67(6):737-743.
• [4]Markel H: Quarantine!: East European Jewish Immigrants and the New York City Epidemics of 1892. Baltimore: JHU Press; 1999.
• [5]Utzinger J, Becker SL, Knopp S, Blum J, Neumayr AL, Keiser J, Hatz CF: Neglected tropical diseases: diagnosis, clinical management, treatment and control. Swiss Med Wkly 2012, 142:24.
• [6]Hotez P, Ottesen E, Fenwick A, Molyneux D: The neglected tropical diseases: The ancient afflictions of stigma and poverty and the prospects for their control and elimination. In Hot Topics in Infection and Immunity in Children III. Edited by Pollard AJ, Finn A. Online: Springer US; 2006:23-33.
• [7]Ball P: Poor trapped in poverty by disease. Nature News 2009. doi:10.1038/news.2009.1130
• [8]Jha P, Mills A, Hanson K, Kumaranayake L, Conteh L, Kurowski C, Nguyen SN, Cruz VO, Ranson K, Vaz LM, Yu S, Morton O, Sachs JD: Improving the health of the global poor. Science 2002, 295(5562):2036-2039.
• [9]Hotez P, Fenwick A, Savioli L, Molyneux D: Rescuing the bottom billion through control of neglected tropical diseases. Lancet 2009, 373:6.
• [10]Braveman P, Gruskin S: Poverty, equity, human rights and health. Bull World Health Organ 2003, 81(7):539-545.
• [11]Assembly UNG: International Bill of Human Rights. Geneva: In Edited by UN; 1996.
• [12]Isah EC, Omorogbe VE, Orji O, Oyovwe L: Self-reported absenteeism among hospital workers in Benin City, Nigeria. Ghana Med J 2008, 42(1):2-7.
• [13]Aylward RB, Alwan A: Polio in Syria. Lancet 2014, 383(9916):489-491.
• [14]United Nations General Assembly: International covenant on civil and political rights. In Resolution 220A (XXI). Geneva: United Nations; 1976.
• [15]United Nations General Assembly: International covenant on economic, social and cultural rights. In Resolution 220A (XXI). Geneva: United Nations; 1976.
• [16]Ruggie JG, United Nations High Commission on Rights: Guiding Principles on Business and Human Rights: Implementing the United Nations “Protect, Respect and Remedy” Framework. Geneva: United Nations; 2011.
• [17]United Nations. General Assembly: Universal Declaration of Human Rights, vol. Resolution 217 A (III). New York: United Nations; 1948.
• [18]FAO, Committee on World Food Security: Voluntary Guidelines on the Responsible Governance of Tenure of Land, Fisheries and Forests in the Context of National Food Security. Rome: Food and Agriculture Organization of the United Nations; 2012:48.
• [19]ICMM Secretariat: Guiding principles for the implementation of the UN ‘Protect Respect and Remedy’ framework. In ICMM Response to the Special Representative of the Secretary General on the Issue of Business and Human Rights. London: ICMM; 2011:2.
• [20]IPIECA: IPIECA Participates at UN Business and Human Rights Forum in Geneva. London: IPIECA; 2012.
• [21]Ruggie JG: Just Business: Multinational Corporations and Human Rights. Volume 1. New York: WW Norton; 2013.
• [22]Thomason J, Hancock M: PNG Mineral Boom: Harnessing the Extractive Sector to Deliver Better Health Outcomes. Canberra: Crawford School of Public Policy, Australian National University; 2011:35.
• [23]Whiteside A, Loewenson R: Socio-economic implications of HIV/AIDS in Southern Africa. In Towards a New Partnership with Africa: Challenges and Opportunities. Uppsala: Nordiska Afrikainstitutet; 1998.
• [24]Institute of Medicine: For the public’s Health: Investing in a Healthier Future. Washington DC: Medicine Io; 2012.
• [25]Mackenzie CD, Homeida MM, Hopkins AD, Lawrence JC: Elimination of onchocerciasis from Africa: possible? Trends Parasitol 2012, 28(1):16-22.
• [26]Prichard RK, Basanez MG, Boatin BA, McCarthy JS, Garcia HH, Yang GJ, Sripa B, Lustigman S: A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis 2012, 6(4):e1549.
• [27]Armstrong Schellenberg J, Bryce J, de Savigny D, Lambrechts T, Mbuya C, Mgalula L, Wilczynska K, Tanzania IM-CEHFSSG: The effect of integrated management of childhood illness on observed quality of care of under-fives in rural Tanzania. Health Policy Plan 2004, 19(1):1-10.
• [28]Wang L-D, Chen H-G, Guo J-G, Zeng X-J, Hong X-L, Xiong J-J, Wu X-H, Wang X-H, Wang L-Y, Xia G, Hao Y, Chin DP, Zhou X-N: A strategy to control transmission of schistosoma japonicum in China. N Engl J Med 2009, 360(2):121-128.
• [29]Yamin AE: From ideals to tools: applying human rights to maternal health. PLoS Med 2013, 10(11):e1001546.
• [30]Fine PE: Leprosy: the epidemiology of a slow bacterium. Epidemiol Rev 1982, 4(1):161-188.
• [31]Perera M, Whitehead M, Molyneux D, Weerasooriya M, Gunatilleke G: Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis. PLoS Negl Trop Dis 2007, 1(2):e128.
• [32]Castro A, Farmer P: Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in Haiti. Am J Public Health 2005, 95(1):53-59.
• [33]Jukes MC, Nokes CA, Alcock KJ, Lambo JK, Kihamia C, Ngorosho N, Mbise A, Lorri W, Yona E, Mwanri L, Baddeley AD, Hall A, Bundy DAP, Partnership for Child Development: Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren. Trop Med Int Health 2002, 7(2):104-117.
• [34]Weiss MG: The nature of stigma and new challenges of leprosy control. In 18th Annual International Leprosy Congress. Brussels: International Leprosy Congress; 2013.
• [35]Meel BL: 1. The myth of child rape as a cure for HIV/AIDS in Transkei: a case report. Med Sci Law 2003, 43(1):85-88.
• [36]Rohleder P: ‘They don’t know how to defend themselves’: talk about disability and HIV risk in South Africa. Rehabilitation in Practice 2010, 32(10):855-863.
• [37]Yeager R: HIV/AIDS: implications for development and security in Sub-Saharan Africa. In Civil-Military Alliance to Combat HIV & AIDS. Rolle, Switzerland and Morgantown, WV, USA: CMA; 2003.
• [38]Namuigi P, Phuanukoonnon S: Barriers to measles immunization: the beliefs and attitudes of caregivers in Goroka, Eastern Highlands Province, Papua New Guinea. P N G Med J 2005, 48(3–4):183-187.
• [39]Phuanukoonnon S, Maraga S, Gouda H, Vallely A, Horwood P, Soli K, Pulford J, Rarau P, Vengiua G, Kumai J, Cross G, Pellegrini M, Greenhill A, Siba P: Report of partnership in health project (PiHP) January to June 2013. Port Moresby, PNG: Papua New Guinea Institute of Medical Research (PNGIMR) 2013.
• [40]UK National Audit Office: Department for International Development: Aid to Malawi. London: International Affairs; 2009.
• [41]Beyrer C, Villar JC, Suwanvanichkij V, Singh S, Baral SD, Mills EJ: Neglected diseases, civil conflicts, and the right to health. Lancet 2007, 370(9587):619-627.
• [42]Cousins S: Polio outbreak in Syria. Nature Middle East 2013. doi:10.1038/nmiddleeast.2013.201
• [43]Kamal SM, El Sayed KK: Immune modulation by helminthic infections: worms and viral infections. Parasite Immunol 2006, 28(10):483-496.
• [44]Sachs J, Malaney P: The economic and social burden of malaria. Nature 2002, 415(6872):680-685.
• [45]Sachs J: Common Wealth: Economics for a Crowded Planet. New York: Penguin Group USA; 2009.
• [46]Bleakley H: Disease and development: evidence from hookworm eradication in the American South. Q J Econ 2007, 122(1):73-117.
• [47]Horton R: Offline: Who cares about human rights anyway? Lancet 2013, 382(9902):1390.
• [48]Cherniak M: The Hawk’s Nest Incident: America’s Worst Industrial Disaster. New Haven: Yale; 1989.
• [49]Li S, Gaur A: Financial giants and moral pygmies?: multinational corporations and human rights in emerging markets. Int J Emerg Market 2014, 9(1):11-32.
• [50]Butler CD: Infectious disease emergence and global change: thinking systemically in a shrinking world. Infectious Diseases of Poverty 2012, 1(5):17.
• [51]Daggy R, Page R: Aramco’s preventive medicine program. Medical Bulletin 1956, 16:9.
• [52]Franz KH: Contributions of American industry in tropical medicine. Bull N Y Acad Med 1968, 44(6):747-754.
• [53]Keiser J, Singer BH, Utzinger J: Reducing the burden of malaria in different eco-epidemiological settings with environmental management: a systematic review. Lancet Infect Dis 2005, 5(11):695-708.
• [54]Coffeng LE, Stolk WA, Zouré HGM, Veerman JL, Agblewonu KB, Murdoch ME, Noma M, Fobi G, Richardus JH, Bundy DAP, Habbema D, de Vlas SJ, Amazigo UV: African programme for onchocerciasis control 1995–2015: Model-estimated health impact and cost. PLoS Negl Trop Dis 2013, 7(1):e2032.
• [55]WHO: Global report for research on infectious diseases of poverty. In Special Programme for Research and Training in Tropical Diseases. Geneva: WHO; 2012.
• [56]Kleinschmidt I, Sharp B, Benavente LE, Schwabe C, Torrez M, Kuklinski J, Morris N, Raman J, Carter J: Reduction in infection with Plasmodium falciparum one year after the introduction of malaria control interventions on Bioko Island, Equatorial Guinea. Am J Trop Med Hyg 2006, 74(6):972-978.
• [57]Coyne PE, Berk DW: The Mectizan (Ivermectin) Donation Program for Riverblindness as a Paradigm for Pharmaceutical Industry Donation Programs. Volume 31570. Geneva: WHO; 2001.
• [58]Vagelos PR, Galambos L: The Moral Corporation: Merck Experiences. Cambridge: Cambridge University; 2006.
• [59]World Economic Forum (WEF): Global Health Initiative: Private Sector Intervention Case Example: Using a Direct Service Model to Provide Workplace Prevention, Care, Support and Treatment. Cologny and Geneva: WEF; 2004.
• [60]Krieger GR, Magnus M, Hassig S: HIV/AIDS prevention programs: methodologies and insights from the dynamic modeling literature. Clinics in Occupational and Environmental Medicine 2004, 4(1):45-69.
• [61]Fielding KL, Grant AD, Hayes RJ, Chaisson RE, Corbett EL, Churchyard GJ: Thibela TB: design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa. Contemporary clinical trials 2011, 32(3):382-392.
• [62]McBride D: Missions for Science: U.S. Technology and Medicine in America’s African World. New Brunswick, NJ: Rutgers University Press; 2002.
• [63]Mayson DT-W, Sawyer A: Labour in Liberia. Rev Afr Polit Econ 1979, 6(14):3-15.
• [64]United Nations: Human Rights in Liberia’s Rubber Plantations: Tapping into the Future. Monrovia: UN Mission in Liberia; 2006:88.
• [65]Schechter PA: Exploring the Decolonial Imaginary: Four Transnational Lives. New York: Palgrave Macmillan; 2012.
• [66]Carter KR: Amending the alien tort claims act: protecting human rights or closing off corporate accountability. Case Western Reserve JIL 2007, 38(3–4):23.
• [67]Portney PR, Stavins RN: Public Policies for Environmental Protection. Washington, D.C: Resources for the Future; 2000.
• [68]Bhatia R, Wernham A: Integrating human health into environmental impact assessment: an unrealized opportunity for environmental health and justice. Environ Health Perspect 2008, 116(8):991-1000.
• [69]Warhurst A: Corporate social responsibility in the mining industries. MERN Research Bulletin and Newsletter 1998, 13–14:16.
• [70]Maine D, Yamin AE: Maternal mortality as a human rights issue: measuring compliance with international treaty obligations. HRQ 1999, 21(3):563-607.
• [71]Clapham A, Rubio MG: The obligations of states with regard to non-state actors in the context of the right to health. In Health and Human Rights Working Paper Series. Geneva: WHO; 2002.
• [72]Salcito K, Utzinger J, Weiss MG, Münch AK, Singer BH, Krieger GR, Wielga M: Assessing human rights impacts in corporate development projects. Environ Impact Assess Rev 2013, 42:39-50.
• [73]Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J: Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006, 6(7):411-425.
• [74]Al-Tuhami HA, Turkistani AM, Nooh RM: Chickenpox outbreak among laborers in a company compound north of Riyadh, 2001. Saudia Arabia Saudi Epidemiology Bulletin 2001, 8(4):3.
• [75]Cortes H, Morillas-Márquez F, Valero A: Malaria in Mauritania: the first cases of malaria endemic to Nouakchott. Tropical Med Int Health 2003, 8(4):297-300.
• [76]Jochelson K, Mothibeli M, Leger JP: Human immunodeficiency virus and migrant labor in South Africa. International journal of health services: planning, administration, evaluation 1991, 21(1):157-173.
• [77]Balfour-Kaipa TM: Our journey on TB, HIV/AIDS in the South African mining industry. Johannesburg: ICMM Health and Safety Conference Report; 2012.
• [78]Schneider V: Silicosis: The Curse of Lesotho’s Miners. Maseru, Lesotho: Al Jazeera; 2014.
• [79]Peipins LA, Lewin M, Campolucci S, Lybarger JA, Miller A, Middleton D, Weis C, Spence M, Black B, Kapil V: Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA. Environ Health Perspect 2003, 111(14):1753-1759.
• [80]Packard RM: White Plague, Black Labor: Tuberculosis and the Political Economy of Health and Disease in South Africa. Oakland: University of California; 1989.
• [81]Jones BA, Grace D, Kock R, Alonso S, Rushton J, Said MY, McKeever D, Mutua F, Young J, McDermott J, Pfeiffer DU: Zoonosis emergence linked to agricultural intensification and environmental change. PNAS 2013, 110(21):8399-8404.
• [82]Benfica RMS: An Analysis of Income Poverty Effects in Cash Cropping Economies in Rural Mozambique: Blending Econometric and Economy-Wide Models. Michigan State: Dissertation; 2006.
• [83]Lecours N, Almeida GEG, Abdallah JM, Novotny TE: Environmental health impacts of tobacco farming: a review of the literature. Tob Control 2012, 21(2):191-196.
• [84]Guhl F, Pinto N, Aguilera G: Sylvatic triatominae: a new challenge in vector control transmission. Mem Inst Oswaldo Cruz 2009, 104(1):71-75.
• [85]Millen JV, Holtz TH: Dying for growth, Part I: Transnational corporations and the health of the poor. In Dying for Growth: Global Inequality and the Health of the Poor. Edited by Kim JY, Millen JV, Irwin A, Gershman J. Monroe, ME: Common Courage; 2000:177-223.
• [86]Monshipouri M, Welch CEJ, Kennedy ET: Multinational corporations and the ethics of global responsibility: Problems and possibilities. HRQ 2003, 25:25.
• [87]Forsythe DP: Human Rights in International Relations. Cambridge: Cambridge University Press; 2012.
• [88]Salama P, Laurence B, Nolan ML: Health and human rights in contemporary humanitarian crises: is Kosovo more important than Sierra Leone? BMJ 1999, 319(7224):1569-1571.
• [89]Feerick JD: Doing well by doing good? A new normative perspective on corporate social responsibility. Fordham Environmental Law Review 2013, 25:1-9.
• [90]Stiglitz JE: Globalization and its Discontents. New York: Norton; 2003.
• [91]Meier BM, Fox A: Development as health: employing the collective right to development to achieve the goals of the individual right to health. Human Rights Quarterly 2008, 30:259-355.
• [92]Bernstein A, Greenwald C: Benchmarking corporate policies on labor and human rights in global supply chains. In Pensions and Capital Stewardship Project, Labor and Worklife Program. Volume 5. Cambridge, MA: Harvard Law School; 2009::38.
• [93]Kozarsky P, Keystone JS, Freedman DO, Nothdurft HD, Connor BA: Travel Medicine E- Book: Expert Consult. St. Louis: Elsevier Health Sciences; 2008.
• [94]Bayer R, Fairchild AL: Changing the paradigm for HIV testing–the end of exceptionalism. N Engl J Med 2006, 355(7):647-649.
• [95]King M, King E: AIDS, Surgery and Life: A Malawi Mosaic. New York: Arco Publishing; 2007.
• [96]Baschetti R: HIV/AIDS and human rights. Lancet 2003, 361(9362):1056.
• [97]Corburn J: Confronting the challenges in reconnecting urban planning and public health. Am J Public Health 2004, 94(4):541-546.
• [98]Sexton K: Socioeconomic and racial disparities in environmental health: is risk assessment part of the problem or part of the solution. Hum Ecol Risk Assess 2000, 6(4):561-574.
• [99]Fox AM, Meier BM: Health as freedom: addressing social determinants of global health inequities through the human right to development. Bioethics 2009, 23(2):112-122.
• [100]Jobin W: Dams and Disease: Ecological Design and Health Impacts of Large Dams, Canals and Irrigation Systems. New York: Routeledge; 1999.
• [101]Post Courier: Stakeholders join hands to address health issues. In Papua New Guinea Post Courier. Papua New Guinea: Post Courier; 2014:1.
• [102]Songco JA: Do Rural Infrastructure Investments Benefit the Poor?: Evaluating Linkages: a Global View, a Focus on Vietnam. Washington, D.C: World Bank Publications; 2002.
• [103]OECD: Morocco - Socioeconomic influence of rural roads. In Highway Project. Volume 4. Washington, D.C: OECD and World Bank Independent Evaluation Group; 1996.
• [104]Bates SJ, Trostle J, Cevallos WT, Hubbard A, Eisenberg JNS: Relating diarrheal disease to social networks and the geographic configuration of communities in rural Ecuador. Am J Epidemiol 2007, 166(9):1088-1095.
• [105]Magnussen L, Ehiri J, Jolly P: Comprehensive versus selective primary health care: lessons for global health policy. Health Aff (Millwood) 2004, 23(3):167-176.
• [106]Kolbe-Alexander TL, Proper KI, Lambert EV, van Wier MF, Pillay JD, Nossel C, Adonis L, Van Mechelen W: Working on wellness (WOW): a worksite health promotion intervention programme. BMC Public Health 2012, 12:372.
• [107]Kolbe-Alexander TL, Conradie J, Lambert EV: Clustering of risk factors for non-communicable disease and healthcare expenditure in employees with private health insurance presenting for health risk appraisal: a cross-sectional study. BMC Public Health 2013, 13:1213.
• [108]Zinsstag J, Schelling E, Bonfoh B, Fooks AR, Kasymbekov J, Waltner-Toews D, Tanner M: Towards a ‘One Health’ research and application tool box. Vet Ital 2009, 45(1):121-133.
• [109]Remais JV, Zeng G, Li G, Tian L, Engelgau MM: Convergence of non-communicable and infectious diseases in low- and middle-income countries. Int J Epidemiol 2013, 42(1):221-227.
• [110]Abebe SM, Berhane Y, Worku A, Assefa A: Diabetes mellitus in North West Ethiopia: a community based study. BMC Public Health 2014, 14:97.
• [111]Unwin N, Alberti KG: Chronic non-communicable diseases. Ann Trop Med Parasitol 2006, 100(5–6):455-464.
• [112]Krieger N, Birn AE: A vision of social justice as the foundation of public health: commemorating 150 years of the spirit of 1848. Am J Public Health 1998, 88(11):1603-1606.
• [113]Szreter S: Rapid economic growth and ‘the four Ds’ of disruption, deprivation, disease and death: public health lessons from nineteenth-century Britain for twenty-first-century China? Tropical medicine & international health: TM & IH 1999, 4(2):146-152.
• [114]Brijnath B, Butler CD, McMichael AJ: In an interconnected world: joint research priorities for the environment, agriculture and infectious disease. Infect Dis Poverty 2014, 3(2):1-3.
• [115]Castro MC, Fisher MG: Is malaria illness among young children a cause or a consequence of low socioeconomic status? evidence from the united Republic of Tanzania. Malar J 2012, 11(1):161-173.
• [116]Paladin: Paladin Energy Ltd - Investor Relations. Subiaco: Paladi; 2009. http://ir.paladinenergy.com.au/FormBuilder/DocumentDownload.ashx?item=DQO_aGVodUuaD1OG9ZlZYQ&Preview=1 webcite
• [117]Molyneux DH, Hotez PJ, Fenwick A: “Rapid-impact interventions”: How a policy of integrated control for Africa’s neglected tropical diseases could benefit the poor. PLoS Med 2005, 2(11):e336.
• [118]WHO: Technical report of the TDR disease reference group on zoonoses and marginalized infectious diseases of poverty. In WHO Tech Rep Ser. Geneva: WHO; 2012.
• [119]Zinsstag J, Schelling E, Wyss K, Mahamat MB: Potential of cooperation between human and animal health to strengthen health systems. Lancet 2005, 366(9503):2142-2145.